Instrument overview

PURRHyperliquid Strategies Inc

StockNasdaqUnited StatesHealth careEU retail investors: available

+1.1% today

No score: too little data.

No dividend.

Hyperliquid Strategies Inc (PURR) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €2.2B.

Not scored: not enough data for a fair comparison.

Red flags and notes

  • Short history Less than one year of prices: not ranked yet.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

P/E
9.6
P/B
0.7
EV/EBIT
1.7
Market cap (EUR)
€2.2B

Profitability and debt

Return on equity
27.6%
Return on invested capital
30.4%

Dividends

Dividend yield
0.00%
Years without a lower dividend
0

Returns and risk

1 day
+1.1%
1 month
−19.8%
Volatility, 1 yr
103.6%
Max drawdown, 1 yr
−45.6%

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

Similar companies

Same sector and region, closest in market value.

UFPTUFP Technologies Inc.8/100.0%41.0%
MDPediatrix Medical Group10/100.0%43.6%
CLDXCelldex Therapeutics Inc.1/100.0%36.4%
SDGRSchrodinger Inc1/100.0%87.8%
SEPNSepterna Inc.1/100.0%174.1%
ARDTArdent Health Inc.—/100.0%24.8%
PVLAPalvella Therapeutics Inc.—/100.0%123.7%
RXRXRecursion Pharmaceuticals, Inc.1/100.0%−17.6%

News and filings

What the marks mean
  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

No published ratings in the last 12 months.